Poor aqueous solubility of drugs is becoming an increasingly pronounced challenge in the formulation and development of drug delivery systems. Issues associated with poor solubility can lead to low bioavailability resulting in suboptimal drug delivery [1] . Moreover, poorly water-soluble drugs need to be formulated in co-solvents or surfactant solutions to enhance their solubility, but many of these solutions are responsible for the severe side effects [2] . The introduction of nanotechnology in the field of drug delivery has enabled the development of new approaches for the treatment of several diseases, to improve efficiency and safety of drugs, by controlling the drug-release rate and place [3] . Poly(lactic-co-glycolic) acid (PLGA) is the FDA-approved copolymer that attracts considerable interest as a base material for biomedical and pharmaceutical applications, due to its biocompatibility and biodegradability [4] . Nanoprecipitation method is a one-step process, generally used to incorporate hydrophobic drugs in the polymer matrix to obtain nanoparticles. Moreover, electrospinning technique is a versatile approach for encapsulating therapeutic agents in nanofibers. Nano-sized dosage forms possess large surface area to volume ratio that alters the chemical, physical, and biological properties of the dosage form, and consequently improves the drug pharmacokinetics and pharmacodynamics. Furthermore, such nanodrug delivery systems provide sustained drug release for a prolonged time [5] .
